106 related articles for article (PubMed ID: 3671775)
21. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
[TBL] [Abstract][Full Text] [Related]
22. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate.
Petrovich Z; Lieskovsky G; Langholz B; Formenti S; Baert L; Streeter O; Skinner DG
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):139-47. PubMed ID: 9422570
[TBL] [Abstract][Full Text] [Related]
23. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
[TBL] [Abstract][Full Text] [Related]
25. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
[TBL] [Abstract][Full Text] [Related]
26. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa.
Gwozdz JT; Morrison WH; Garden AS; Weber RS; Peters LJ; Ang KK
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):127-35. PubMed ID: 9300747
[TBL] [Abstract][Full Text] [Related]
27. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.
Pommier P; Chabaud S; Lagrange JL; Richaud P; Lesaunier F; Le Prise E; Wagner JP; Hay MH; Beckendorf V; Suchaud JP; Pabot du Chatelard PM; Bernier V; Voirin N; Perol D; Carrie C
J Clin Oncol; 2007 Dec; 25(34):5366-73. PubMed ID: 18048817
[TBL] [Abstract][Full Text] [Related]
28. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
29. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
[TBL] [Abstract][Full Text] [Related]
30. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome of radical radiation therapy for prostatic carcinoma: 1967-1987.
Hahn P; Baral E; Cheang M; Math MC; Kostyra J; Roelss R
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):41-7. PubMed ID: 12118564
[TBL] [Abstract][Full Text] [Related]
32. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
33. High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experience.
Detti B; Baki M; Becherini C; Saieva C; Scartoni D; Giacomelli I; Trombetta L; Muntoni C; Olmetto E; Francolini G; Turkaj A; Topulli J; Ciabatti C; Carta G; Poggesi L; Delli Paoli C; Terziani F; Grassi R; Livi L
Radiol Med; 2019 May; 124(5):422-431. PubMed ID: 30607866
[TBL] [Abstract][Full Text] [Related]
34. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
35. External beam radiotherapy dose response of prostate cancer.
Pollack A; Zagars GK
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1011-8. PubMed ID: 9392538
[TBL] [Abstract][Full Text] [Related]
36. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
37. External beam radiotherapy for carcinoma of the prostate.
Sagerman RH; Chun HC; King GA; Chung CT; Dalal PS
Cancer; 1989 Jun; 63(12):2468-74. PubMed ID: 2720597
[TBL] [Abstract][Full Text] [Related]
38. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.
Kupelian PA; Reddy CA; Carlson TP; Altsman KA; Willoughby TR
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):904-12. PubMed ID: 12095556
[TBL] [Abstract][Full Text] [Related]
39. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
40. Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10).
Kupelian PA; Buchsbaum JC; Reddy CA; Klein EA
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):621-5. PubMed ID: 11395228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
